Pearson PLC Sponsored ADR Aktie News

BETHESDA, Md.--(BUSINESS WIRE)--HoloMD, the AI-powered remote therapeutic monitoring (RTM) platform for psychiatry, today announced the appointment of veteran med-tech operator Jim Pearson as Executive Chairman, reuniting him with longtime collaborator Joseph (“Joe”) Mark, a Director on HoloMD's Board. This marks the pair's third partnership building category-defining healthcare companies that ...

HOBOKEN, N.J. , Oct. 23, 2025 /PRNewswire/ -- Pearson (FTSE: PSON.L), the world's lifelong learning company, today announced a partnership with the Center for Energy Workforce Development (CEWD).

Pearson's rating is upgraded to "Buy" after a strong Q3 and optimistic Q4 guidance. The Virtual Learning and Assessment & Qualifications segments outperformed, which translated into above-consensus results. PSO's Q4 outlook is favorable, with new contracts, Salesforce certification exclusivity, and ELS growth from a Cognizant partnership.

Pearson plc (NYSE:PSO ) Q3 2025 Sales Call October 17, 2025 3:30 AM EDT Company Participants Omar Abbosh - CEO & Executive Director Sally Kate Johnson - CFO & Executive Director Conference Call Participants James Tate - Goldman Sachs Group, Inc., Research Division Adam Berlin - UBS Investment Bank, Research Division Nick Dempsey - Barclays Bank PLC, Research Division Steven Craig Liechti - Deut...

Pearson PLC (LSE:PSON) shares rose 5% to 1,150p on Friday, defying triple-digit losses across the wider London market, after the education group posted another solid quarter and reaffirmed its full-year guidance. The company reported a 4% rise in underlying sales for the three months to September and a 2% increase year-to-date, with chief executive Omar Abbosh calling it “another quarter of goo...

Pearson PLC (LSE:PSON) has delivered another solid quarter, reporting a 4% rise in underlying group sales for the three months to September and a 2% increase for the year so far. The company said it remains on track to meet full-year expectations, with stronger growth expected in the final quarter.

Continued execution against our strategic priorities; on track to deliver on 2025 market expectations 1 with clear drivers for stronger growth in Q4. LONDON , Oct. 17 2025 /PRNewswire/ -- Highlights Pearson 2025 Nine Month Trading Update (Unaudited) Underlying Group sales growth accelerating to 4% in Q3, resulting in 2% growth for the nine-month period.

Developed by Pearson Clinical Assessment and powered by Samsung, Revibe supports attention and self-regulation through discreet, AI-driven reminders HOBOKEN, N.J. , Oct. 1, 2025 /PRNewswire/ -- For millions of people, especially students, the ability to focus in a world of distractions can be the single greatest barrier to learning.